Neddylation inhibition ameliorates steatosis in NAFLD by boosting hepatic fatty acid oxidation via the DEPTOR-mTOR axis

• Main Authors: Marina Serrano-Maciá (Author), Jorge Simón (Author), Maria J. González-Rellan (Author), Mikel Azkargorta (Author), Naroa Goikoetxea-Usandizaga (Author), Fernando Lopitz-Otsoa (Author), Diego Saenz De Urturi (Author), Rubén Rodríguez-Agudo (Author), Sofia Lachiondo-Ortega (Author), Maria Mercado-Gomez (Author), Virginia Gutiérrez de Juan (Author), Maider Bizkarguenaga (Author), David Fernández-Ramos (Author), Xabier Buque (Author), Guido A. Baselli (Author), Luca V.C. Valenti (Author), Paula Iruzubieta (Author), Javier Crespo (Author), Erica Villa (Author), Jesus M. Banales (Author), Matias A. Avila (Author), Jose J.G. Marin (Author), Patricia Aspichueta (Author), James Sutherland (Author), Rosa Barrio (Author), Ugo Mayor (Author), Félix Elortza (Author), Dimitris P. Xirodimas (Author), Rubén Nogueiras (Author), Teresa C. Delgado (Author), María Luz Martínez-Chantar (Author)
• Format: Book
• Published: Elsevier, 2021-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective: Neddylation is a druggable and reversible ubiquitin-like post-translational modification upregulated in many diseases, including liver fibrosis, hepatocellular carcinoma, and more recently, non-alcoholic fatty liver disease (NAFLD). Herein, we propose to address the effects of neddylation...